The effects of ketanserin, methysergide and LY 53857 on sympathetic nerve activity
- 1 July 1985
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 113 (3) , 295-303
- https://doi.org/10.1016/0014-2999(85)90076-7
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Evidence for common pharmacological properties of [3H]5-hydroxytryptamine binding sites, presynaptic 5-hydroxytryptamine autoreceptors in CNS and inhibitory presynaptic 5-hydroxytryptamine receptors on sympathetic nervesNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1983
- Mechanism of the Hypotensive Effect of KetanserinJournal of Cardiovascular Pharmacology, 1982
- Ketanserin—a novel antihypertensive drug?Journal of Pharmacy and Pharmacology, 1982
- The Antihypertensive Effects of a Pure and Selective Serotonin-Receptor Blocking Agent (R 41 468) in Elderly PatientsAngiology, 1981
- Review of the role of the central serotonergic neuronal system in blood pressure regulation.Hypertension, 1980
- EVIDENCE FOR TWO TYPES OF EXCITATORY RECEPTOR FOR 5‐HYDROXYTRYPTAMINE IN DOG ISOLATED VASCULATUREBritish Journal of Pharmacology, 1980
- Reduction in blood pressure, sympathetic nerve discharge and centrally evoked pressor responses by methysergide in anesthetized catsEuropean Journal of Pharmacology, 1977
- Centrally mediated antihypertensive and bradycardic effects of methysergide in spontaneously hypertensive ratsEuropean Journal of Pharmacology, 1976
- Centrally mediated hypotension and bradycardia by methysergide in anesthetized dogsEuropean Journal of Pharmacology, 1975
- The animal pharmacology of drugs used in the treatment of migraineJournal of Pharmacy and Pharmacology, 1975